News

Infectious Disease Advisor4h
FDA Approves Novavax’s COVID-19 Vaccine Nuvaxovid
The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years ...
FDA may limit future COVID-19 boosters to seniors, those at higher risk for complications
US Food and Drug Administration officials are changing the agency's standards for updated COVID-19 booster shots with focus ...
Novavax: Nuvaxovid FDA Approval Unlocks Several Bullish Stimuli
Novavax's full FDA approval for NUVAXOVID is a transformative milestone, unlocking a $175M Sanofi payment and validating ...
FDA may limit future Covid-19 shots to older people and those at risk of serious infection
The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit ...
Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for new clinical trials
The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at ...
News On 648m
Trump administration restricts eligible COVID vaccine recipients
FDA changes COVID-19 vaccine approval policy, major trials now required for widespread use. Higher risk individuals still ...
FDA sets new COVID booster guidelines for healthy adults under 65
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
FDA approves Novavax COVID-19 shot with restrictions
The 2025 "American Idol" champion stops by "GMA" to perform his new single, “Heal,” and reflect on his path to victory. A new Trump administration vaccine policy will limit access to COVID-19 shots.
FDA Limits COVID-19 Boosters to Seniors, Other High-Risk Groups
WEDNESDAY May 21, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has decided that only seniors and ...